A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without M7824 bintrafusp alfa as First-line Treatment of Biliary Tract Cancer

Brief Summary

Type:
Liver

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT04066491

Study #:
STUDY00145016

Start Date:
Oct 01, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04066491

View Complete Trial Details & Eligibility at ClinicalTrials.gov